{
  "model_id": "PN-REGEN-2026-v1",
  "concept": "High-Concentration Polynucleotide (PN) Matrix for Deep Tissue Repair",
  "domain": "Dermatology / Tissue Engineering",
  "target_receptor": "Adenosine A2A Receptor",
  "mechanism": {
    "molecular_action": "Purine salvage pathway activation; Adenosine A2A receptor agonism",
    "delivery_vector": "High-viscosity PN gel (20mg/mL)",
    "biological_effects": [
      "VEGF induction (Angiogenesis)",
      "Fibroblast migration and proliferation",
      "Extracellular matrix (ECM) synthesis enhancement"
    ]
  },
  "predicted_outcomes": {
    "skin_thickness": "+15-20% after 4 sessions",
    "elasticity": "Improved biomechanical properties",
    "hydration": "Increased due to hydrophilic nature of PN"
  },
  "safety_profile": {
    "immunogenicity": "Extremely Low (purified DNA, no proteins)",
    "biocompatibility": "High (homologous to human DNA structure)"
  },
  "clinical_relevance": {
    "indications": [
      "Thinning skin (under-eye, neck)",
      "Chronic inflammation",
      "Wound healing",
      "Hair loss (PDRN variant)"
    ],
    "synergy": "High potential with non-crosslinked HA or Exosomes"
  },
  "status": "Internal Synthesis / Supplemental Model",
  "validation_required": true,
  "timestamp": "2026-02-14T18:18:00+09:00"
}
